As of 2024-12-15, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (54.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -75754.4%.
The range of the Relative Valuation is (51.41) - (54.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 30.8x | 29.2x |
| Forward P/E multiples | 27.5x - 29.3x | 29.2x |
| Fair Price | (51.41) - (54.85) | (54.62) |
| Upside | -71298.1% - -76065.3% | -75754.4% |
| Date | P/E |